MARKETSPERPSLIVE39
Cash
Portfolio
TrendingElectionsPoliticsCultureSportsCryptoCommoditiesClimateEconomicsMentions

Finance

Tech & Science
Product
Kalshi ProPerpetual FuturesMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
TrendingElectionsPoliticsCultureSportsCryptoCommoditiesClimateEconomicsMentions

Finance

Tech & Science

Industries

All markets
Public Companies Hub
Companies
Indices
Industries
Biotech
Compute
Markets
Industries

NVIDIA H200 · Hourly price on Aug 28 (Week 35)

Above $4.50
2.46x
Above $4.00
1.36x
$148 vol21 markets
Biotech

FDA decision: Venglustat by Sanofi (this year)

Yes
1.01x
No
1.01x
$1 vol1 market
Biotech

FDA decision: Saroglitazar by Zydus Therapeutics (this year)

Yes
1.01x
No
1.01x
$1 vol1 market
Biotech

FDA decision: Rusfertide by Protagonist Therapeutics (this year)

Yes
1.01x
No
1.01x
$1 vol1 market
Industries

NVIDIA RTX 5090 · Hourly price on Aug 28 (Week 35)

Above $0.65
--
Above $0.15
--
$17 vol17 markets
Industries

August 2026: Monthly average compute price of NVIDIA’s RTX 5090

Above $0.75
--
Above $0.25
--
$8 vol8 markets
Biotech

FDA decision: Ivonescimab by Summit Therapeutics (this year)

Yes
1.01x
No
1.01x
$3 vol1 market
Biotech

FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (this year)

Yes
1.01x
No
1.01x
$3 vol1 market
Industries

August 2026: Monthly average compute price of NVIDIA’s H200

Above $3.50
1.25x
Above $1.50
--
$33 vol11 markets
Industries

NVIDIA H100 · Hourly price on Aug 28 (Week 35)

Above $1.00
--
Above $1.25
--
$36 vol12 markets
Industries

August 2026: Monthly average compute price of NVIDIA’s H100

Above $2.00
--
Above $2.25
--
$27 vol9 markets
Industries

What will the price of TrendForce’s DDR5 be at year-end 2027?

Above $105.00
--
Above $25.00
--
$25 vol9 markets
Compute

DDR5 16Gb (2Gx8) 4800/5600 · price on Aug 28 (Week 35)

Above $49.00
--
Above $49.25
--
$60 vol20 markets
Compute

DDR5 16Gb (2Gx8) 4800/5600 · Average price in August 2026

Above $56.00
--
Above $56.25
--
$30 vol40 markets
Compute

DDR5 16Gb (2Gx8) eTT · price on Aug 28 (Week 35)

Above $22.90
--
Above $23.00
--
$60 vol20 markets
Compute

DDR5 16Gb (2Gx8) eTT · Average price in August 2026

Above $22.60
--
Above $22.70
--
$30 vol30 markets
Biotech

FDA decision: Brepocitinib by Priovant Therapeutics (this year)

Yes
1.02x
No
1.01x
$3 vol1 market
Biotech

FDA decision: bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) by Gilead Sciences (this year)

Yes
1.02x
No
1.01x
$3 vol1 market
Biotech

FDA decision: Bepirovirsen by GlaxoSmithKline (this year)

Yes
1.02x
No
1.01x
$3 vol1 market
Biotech

FDA decision: BBP-418 by Ml Bio Solutions Inc. (this year)

Yes
1.02x
No
1.01x
$3 vol1 market
Industries

NVIDIA B200 · Hourly price on Aug 28 (Week 35)

Above $10.00
--
Above $10.50
--
$99 vol33 markets
Industries

August 2026: Monthly average compute price of NVIDIA’s B200

Above $3.00
--
Above $3.50
--
$27 vol9 markets
Biotech

FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (this year)

Yes
1.02x
No
1.01x
$3 vol1 market
Industries

NVIDIA A100 · Hourly price on Aug 28 (Week 35)

Above $1.00
1.03x
Above $1.25
23.4x
$30 vol10 markets